{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:02:40Z","timestamp":1789614160347,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001006","name":"The Breast Cancer Research Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R 37 \\u2013 1R37CA292075-01"],"award-info":[{"award-number":["R 37 \\u2013 1R37CA292075-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.breast.2026.104901","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:07:31Z","timestamp":1786547251000},"page":"104901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1672-9560","authenticated-orcid":false,"given":"Dario","family":"Trapani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Jayachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipra","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy U.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Spanheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Abravanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Radovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Lustberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"George W.","family":"Sledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Tolaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 P.","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.breast.2026.104901_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/annonc\/mdx651","article-title":"Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG international Male breast Cancer Program","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.breast.2026.104901_bib2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1080\/14656566.2020.1763305","article-title":"Pharmacological management of male breast cancer","volume":"21","author":"Duso","year":"2020","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.breast.2026.104901_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccell.2024.03.006","article-title":"Genetic interactions reveal distinct biological and therapeutic implications in breast cancer","volume":"42","author":"Lin","year":"2024","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.breast.2026.104901_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2026.106059","article-title":"Genomic landscape, immune microenvironment and survival in male versus female breast cancer","volume":"11","author":"Trapani","year":"2026","journal-title":"ESMO Open"},{"issue":"22","key":"10.1016\/j.breast.2026.104901_bib5","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO-college of American pathologists guideline update","volume":"41","author":"Wolff","year":"2023","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.breast.2026.104901_bib6","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1002\/cncr.34982","article-title":"Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers","volume":"129","author":"Nazha","year":"2023","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.breast.2026.104901_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"7","key":"10.1016\/j.breast.2026.104901_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-023-02071-0","article-title":"Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target","volume":"40","author":"Darabi","year":"2023","journal-title":"Med Oncol"},{"issue":"4","key":"10.1016\/j.breast.2026.104901_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.breast.2026.104901_bib10","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med"},{"issue":"43","key":"10.1016\/j.breast.2026.104901_bib11","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.breast.2026.104901_bib12","article-title":"PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system","volume":"7","author":"Zimmer","year":"2023","journal-title":"npj Precis Oncol"},{"issue":"10","key":"10.1016\/j.breast.2026.104901_bib13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","volume":"21","author":"Marabelle","year":"2020","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.breast.2026.104901_bib14","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1016\/j.celrep.2017.11.096","article-title":"PRMT5 is a critical regulator of breast cancer stem cell function via histone methylation and FOXP1 expression","volume":"21","author":"Chiang","year":"2017","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.breast.2026.104901_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5483\/BMBRep.2017.50.3.189","article-title":"Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells","volume":"50","author":"Oh","year":"2017","journal-title":"BMB Rep"},{"issue":"10","key":"10.1016\/j.breast.2026.104901_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.trecan.2022.07.001","article-title":"Deciphering the roles of ABCB5 in normal and cancer cells","volume":"8","author":"Duvivier","year":"2022","journal-title":"Trends Cancer"},{"issue":"S2","key":"10.1016\/j.breast.2026.104901_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14337","article-title":"Carcinoembryonic antigen-related cell adhesion molecule 1 in cancer: blessing or curse?","volume":"54","author":"G\u00f6tz","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.breast.2026.104901_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-023-01676-7","article-title":"Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance","volume":"25","author":"Zheng","year":"2023","journal-title":"Breast Cancer Res"},{"issue":"18","key":"10.1016\/j.breast.2026.104901_bib19","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/1078-0432.CCR-24-1363","article-title":"NETosis impact on tumor biology, radiation, and systemic therapy resistance","volume":"30","author":"Mowery","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.breast.2026.104901_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-020-00208-2","article-title":"Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer","volume":"7","author":"Schettini","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.breast.2026.104901_bib21","first-page":"1","article-title":"Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer","volume":"14","author":"Tarantino","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.breast.2026.104901_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10549-024-07495-4","article-title":"Genomic and transcriptomic landscape of HER2-low breast cancer","volume":"209","author":"Bansal","year":"2025","journal-title":"Breast Cancer Res Treat"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626002110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626002110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:33:10Z","timestamp":1789612390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977626002110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":22,"alternative-id":["S0960977626002110"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104901","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104901"}}